A number of cell surface markers are expressed on resting peripheral blood (PB) T cells (1). However, there are a number of surface markers that are expressed only in low proportions or not at all on resting T cells, but that are clearly expressed in varying proportions on activated T cells. Among these markers of activated T cells, the receptors for the Fc portion of IgG (FcyR) are on small fractions of PB sheep erythrocyte (E)-rosetting cells, usually referred to as Ty cells (2, 3). The proportions of FcTR-positive cells increase markedly upon activation of the cell (4). In addition, Ia-like antigens are expressed on a small proportion of freshly isolated circulating T cells; these are included within the Ty fraction (5). Again, upon activation of T cells, variable proportions will express Ia-like antigens (6-8). Recently, a monoclonal antibody (4F2) has been described which binds to a non-Ia, 120,000-mol wt cell surface antigen present on resting PB monocytes, but which is present in negligible amounts on resting PB lymphocytes (9, 10). However, the 4Fz antigen is expressed on a large proportion of lymphocytes which have been activated by mitogen and/or alloantigen stimulation (9).
A number of cell surface markers are expressed on resting peripheral blood (PB) T cells (1) . However, there are a number of surface markers that are expressed only in low proportions or not at all on resting T cells, but that are clearly expressed in varying proportions on activated T cells. Among these markers of activated T cells, the receptors for the Fc portion of IgG (FcyR) are on small fractions of PB sheep erythrocyte (E)-rosetting cells, usually referred to as Ty cells (2, 3) . The proportions of FcTR-positive cells increase markedly upon activation of the cell (4) . In addition, Ia-like antigens are expressed on a small proportion of freshly isolated circulating T cells; these are included within the Ty fraction (5) . Again, upon activation of T cells, variable proportions will express Ia-like antigens (6) (7) (8) . Recently, a monoclonal antibody (4F2) has been described which binds to a non-Ia, 120,000-mol wt cell surface antigen present on resting PB monocytes, but which is present in negligible amounts on resting PB lymphocytes (9, 10) . However, the 4Fz antigen is expressed on a large proportion of lymphocytes which have been activated by mitogen and/or alloantigen stimulation (9) .
The precise identity of the mixed lymphocyte reaction (MLR)-activated specific cytotoxic T cell (CTL) in humans has not been characterized by currently available cell surface markers.
In this study we have analyzed MLR-activated T cells to determine the relationship between specific cytotoxicity and the phenotypic expression of these activation markers. The results indicate that CTL are found exclusively in a population of cells lacking detectable FcyR (FcyR-) but expressing 4F2 antigen. By contrast, CTL were detectable in both the Ia-positive and Ia-negative population of activated T cells.
Materials and Methods
Cell Separations. Mononuclear cells were obtained from heparinized PB by standard FicollHypaque separation and adherent cells were removed from the mononuclear cell suspensions by adherence to plastic Petri dishes. E-rosetting lymphocytes were separated from nonrosetting cells by fractionation of rosetting cells over two sequential Ficoll-Hypaque centrifugations (11) . T cells bearing receptors for IgM (T#) were isolated as previously described (12) . Stimulator cells for the MLR were prepared by two sequential Ficoll-Hypaque fractionations of E-rosetting cells from mononuclear cells to obtain E-rosette-depleted cell suspensions. These cells were then irradiated with 5,000 rad. J. Exp TdR uptake was determined in a scintillation counter. In parallel experiments cells were harvested after 7 d, passed through a Ficoll-Hypaque gradient to remove dead cells, and after washing twice, cells were counted and the percentages of Erosetting cells determined. When the proportion of E-rosettes was >95%, no additional purification was performed. When the proportion was <95%, E-rosetting cells were further isolated by additional Ficoll-Hypaque density gradient centrifugations.
Enumeration and Isolation of MLR-activated Cells Expressing Surface FcyR, la, or 4F2 Antigen. Cells
with surface FcyR were isolated as previously described by a rosetting technique using ox erythrocytes sensitized with purified rabbit IgG antibodies (12) . Rosetting cells (FcTR +) were isolated from nonrosetting cells (FcTR-) by pelleting them at least twice through FicollHypaque gradients. Ox erythrocytes were lysed with NH4Ci buffer. The FcTR-cells were sham-treated with NH4CI. Monoclonal antibodies 4F2 and D1/12 were prepared and used as previously described (10, 13) . For evaluation of the percentage of Ia + and 4F2 + cells and for their isolation, T cell suspensions were reacted with saturating amounts of monoclonal antibody. The D1/12 monoclonal anti-Ia antibody was kindly provided by Dr. R. Accolla and Dr. S. Carrel of the Ludwig Institute for Cancer Research, Epilanges sur Lausanne, Switzerland. A fluoresceinated goat anti-mouse antiserum was used as the second reagent in saturating concentrations for analysis on the fluorescence-activated cell sorter (FACS II; BD FACS Systems, Mountain View, Calif.). Background fluorescence was obtained by FACS analysis of the same cell suspensions incubated with a mouse gamma-2 globulin in place of D1/12 (Ia) or 4F2 monoelonal antibodies. 4F2 or D1/12-1abeled cells were also enumerated and were exclusively isolated by means of a rosetting technique using ox erythrocytes coated with staphylococcal A protein (13) . Both rosetting and nonrosetting cells were treated with NH4CI lysing buffer after isolation.
After activation in the MLR, the proportions of cells positive for Ia or 4F2 antigen were similar in both FACS and rosetting analysis. The percentage of Ia + cells ranged from 30 to 50% of responder T cells; both small and large cells were Ia +. 4F2 antigen-bearing lymphocytes were 40-60% of the responder T cells and were all large cells. FcyR + cells ranged from 20 to 50% of the responder T cells of a 7-d MLR--both large and small cells expressed FcyR.
Cytotoxicity Assay. E-rosetting T cells from a 7-d MLR or T cells fractionated according to
surface FcyR, Ia, or 4F2 antigen were tested for their cytotoxic capacity against the relevant target cells, which had been stimulated for 3 d with phytohemagglutinin. 5 × 10 a target cells labeled with 51Cr were incubated with varying numbers of effector cells (from 1:1 to 100:1 ratios). The plates were centrifuged and then incubated for 4 h at 37°C. Cytolysis was assessed by counting the radioactivity of 0.1 ml supernate for 1 rain in a scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.). The specific lysis was calculated according to the method ofCerottini et al. (14) .
Results and Discussion
Purified T lymphocytes were used as responder cells against allogeneic irradiated E-rosette-depleted cells. After a 7-d MLR, E-rosetting cells were isolated and further fractionated according to the presence of FcTR, surface Ia, or 4F2 antigen. Unfractionated responder T lymphocytes (total T cells) and the various cell fractions bearing or lacking the above-mentioned markers were analyzed for their cytotoxic capability against the relevant target cells. Fig. 1 shows a typical experiment. The presence of Ia-like antigens recognized by D1/12 monoelonal antibody did not discriminate cells manifesting specific cytotoxicity, because unfractionated responder cells, Ia +, and Iafractions killed the target with similar efficiency (Fig. 1) . These experiments were performed four separate times with similar results. On the other hand, fractionation of responder T cells according to surface FcyR demonstrated that cytotoxic cells were present exclusively among the FcyR-fraction (Fig. 2) . These experiments were performed 10 separate times with similar results. By contrast, cytotoxic T cells were restricted to the population bearing 4F2 antigen (Fig. 3) as determined by five separate experiments. It is noteworthy that similar results were obtained in experiments in which purified T# cells were used as responders (data not shown). Thus, responder T cells that express none of these activation markers at the initiation of the MLR (purified T# cells) are equally capable of ultimately expressing them. These results have clearly demonstrated that the MLR-generated CTL are contained in the 4F2 + and FcyR-cell fractions. Therefore, it is possible, after MLR activation, to selectively enrich or deplete specific CTL on the basis of the presence or absence of different activation markers.
Because CTL are restricted to the cells bearing the 4F2 antigen, but lacking detectable FcyR, an obvious question is whether all the 4F2 + cells are FcyR-and, conversely, whether all of the FcyR-cells express 4F2 antigen. Preliminary experiments have shown that this is not the case and that 4F2 + cells include variable proportions of FcyR + cells (up to 30%), whereas FcyR-cells can comprise up to 50% of 4F2-cells. Thus, the combined use of FcyR and 4F2 antibody allows one to further restrict the cytotoxic cells to the 4F2 +, FcyR-fraction, which usually accounts for 30-40% of the responder T cells.
As the fraction of cells that expresses 4F2 antigen includes all the specific CTL, the question arises whether this surface structure is directly involved in the cytotoxic capacity of the cells. In this regard, addition of high concentration of 4F2 monoclonal antibody to the cytolytic assay had no effect on the target cell killing. In addition, it is possible that the positive selection of FcyR + cells generated in MLR by rosetting techniques could affect the cytotoxic capacity of the cells themselves, because it is known that interaction of PB Ty cells with IgG immune complexes induces loss of BRIEF DEFINITIVE REPORT 
Summary
Mixed lymphocyte reaction (MLR)-activated T cells were analyzed according to the expression of various cell surface markers by the specific cytotoxic T lymphocytes (CTL) generated in the MLR. CTL were found exclusively in a population of MLRactivated T cells that lacked detectable FcyR but that expressed a surface antigen recognized by the 4F~ monoclonal antibody. In contrast, CTL were found in both the Ia-positive and Ia-negative cells after MLR activation. Thus, the specific CTL generated in the allogeneic MLR can be identified and isolated by virtue of the expression of a particular cell surface marker.
